Seltorexant for Major Depressive Disorder With Insomnia Symptoms Sees Positive Results
Johnson & Johnson shared positive topline results from the pivotal phase 3 MDD3001 clinical trial evaluating the efficacy and safety of seltorexant as an adjunctive treatment to baseline antidepressants in adult and elderly patients with major …